JENNIFER PANZARELLA: Open Payments
NPI 1013569557 · ONEONTA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 23 payments from 7 companies in 2025. Trend: 2023 $909 · 2024 $925 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $104 |
| PFIZER INC. | 3 | $84 |
| GlaxoSmithKline, LLC. | 5 | $81 |
| AstraZeneca Pharmaceuticals LP | 5 | $73 |
| ABBVIE INC. | 2 | $52 |
| Exact Sciences Corporation | 2 | $37 |
| Abbott Laboratories | 1 | $22 |
Products named: ELIQUIS, VRAYLAR, SHINGRIX, Ozempic, Rybelsus, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA, FARXIGA.
Industry payments across NY — which companies pay providers there.
